Surgical Sealants And Tissue Patches Market Report 2026

Surgical Sealants And Tissue Patches Market Overview

• Surgical Sealants And Tissue Patches market size has reached to $2.56 billion in 2025 • Expected to grow to $4.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: Growth In The Number Of Accidents And Sports-Related Injuries Fueling The Growth Of The Market Due To Rising Participation In High-Impact Activities • Market Trend: Innovative Hydrogel Technology Enhancing Spinal Repair • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Surgical Sealants And Tissue Patches Market?

Surgical sealants and tissue patches are medical devices used to control bleeding, seal tissues, and promote wound healing during surgeries. Sealants are bioadhesive materials that bond tissues, preventing leaks of fluids or air, while tissue patches provide structural support for tissue regeneration. They are commonly used in cardiovascular, orthopedic, and general surgeries to enhance recovery and reduce complications. The main product types in the surgical sealants and tissue patches market are natural and biological sealants, synthetic and polymer-based sealants and hybrid sealants. Natural and biological sealants refer to biocompatible, naturally derived materials used in surgical procedures to achieve tissue adhesion, hemostasis, and wound closure. The key indications include surgical hemostasis, tissue sealing, tissue engineering, and wound closure. These products are used in cardiovascular, neurological, orthopedic, general, urological, and pulmonary surgeries. The primary end users include hospitals, ambulatory surgical centers (ASCs), and specialty clinics.

What Is The Surgical Sealants And Tissue Patches Market Growth Forecast?

The surgical sealants and tissue patches market size is expected to see strong growth in the next few years. It will grow to $4.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, rising focus on reducing post-operative complications, expansion of regenerative medicine applications, growing investments in advanced surgical biomaterials, increasing adoption across specialty surgeries. Major trends in the forecast period include increasing adoption of bioengineered sealants, rising use of synthetic and hybrid adhesives, growing demand for minimally invasive surgical solutions, expansion of advanced hemostatic technologies, enhanced focus on faster wound healing outcomes.

Global Surgical Sealants And Tissue Patches Market Segmentation

1) By Product Type: Natural And Biological Sealants, Synthetic And Polymer-based Sealants, Hybrid Sealants 2) By Indication: Surgical Hemostasis, Tissue Sealing, Tissue Engineering, Wound Closure 3) By Application: Cardiovascular Surgery, Neurological Surgery, Orthopedic Surgery, General Surgery, Urological Surgery, Pulmonary Surgery 4) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics Subsegments: 1) By Natural And Biological Sealants: Fibrin Sealants, Collagen-Based Sealants, Gelatin-Based Sealants, Albumin-Based Sealants 2) By Synthetic And Polymer-based Sealants: Cyanoacrylate-Based Sealants, Polyethylene Glycol (PEG)-Based Sealants, Polyurethane-Based Sealants 3) By Hybrid Sealants: Protein-Polymer Hybrid Sealants, Synthetic-Biologic Composite Sealants, Bioengineered Adhesives

What Is The Driver Of The Surgical Sealants And Tissue Patches Market?

The growth in the number of accidents and sports-related injuries is expected to propel the growth of the surgical sealants and tissue patches market going forward. Accidents and sports-related injuries refer to physical harm or trauma caused by unforeseen incidents, falls, collisions or excessive strain during daily activities or athletic participation. Accidents and sports-related injuries are increasing due to the rising participation in high-impact sports and outdoor activities, which expose individuals to greater physical strain and a higher risk of traumatic injuries. Surgical sealants and tissue patches enhance the treatment of accidents and sports-related injuries by providing quick and effective wound closure, reducing recovery time and the risk of infection. They improve patient outcomes by offering minimally invasive solutions, promoting faster healing and reducing the need for stitches. For instance, in March 2025, according to the Department of Infrastructure, Transport, Regional Development, Communication, and the Arts, an Australia-based government agency, there were 1,292 road fatalities in the 12 months ending February 2025, reflecting a 1.6% rise compared to 2024. Therefore, the growth in the number of accidents and sports-related injuries is driving the growth of the surgical sealants and tissue patches industry.

Key Players In The Global Surgical Sealants And Tissue Patches Market

Major companies operating in the surgical sealants and tissue patches market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Baxter International Inc., Terumo Corporation, Integra LifeSciences Holdings Corporation, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Ocular Therapeutix Inc., Arch Therapeutics Inc., RUA Life Sciences plc, GEM S.r.l., Tissx GmbH, Cohera Medical Inc., CryoLife Inc., Vivostat A/S, Corza Medical, Hemostasis LLC, Surgical Specialties Corporation

Global Surgical Sealants And Tissue Patches Market Trends and Insights

Major companies operating in the surgical sealants and tissue patches market are focusing on developing innovative products, such as absorbable polyethylene glycol (PEG) hydrogel to enhance surgical outcomes by providing rapid, watertight sealing, reducing complications and improving patient recovery in spinal and dural repair procedures. Absorbable polyethylene glycol (PEG) hydrogel is a biocompatible, synthetic polymer-based material that forms a temporary, watertight seal over tissues and is naturally absorbed by the body over time. For instance, in March 2025, Pramand LLC, a US-based medical device company, launched the SpineSeal spine sealant system in the U.S following Food and Drug Administration (FDA) premarket approval. SpineSeal is an absorbable polyethylene glycol (PEG) hydrogel designed to provide a watertight seal over sutured dural repairs during spinal surgery, preventing cerebrospinal fluid (CSF) leakage. The sealant is applied over sutures using a specialized applicator and forms a watertight seal within seconds.

What Are Latest Mergers And Acquisitions In The Surgical Sealants And Tissue Patches Market?

In June 2023, H.B. Fuller Company, a US-based adhesives manufacturing company, acquired Adhezion Biomedical LLC for $95.8 million. With this acquisition, H.B. Fuller expanded its healthcare and medical adhesives portfolio, particularly in the surgical adhesives and wound care markets. This strengthened its position in the medical adhesives market and gave access to Adhezion's advanced cyanoacrylate products for various clinical uses. Adhezion Biomedical LLC is a US-based medical device company focused on surgical adhesives, sealants, and tissue patches.

Regional Outlook

North America was the largest region in the surgical sealants and tissue patches market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Surgical Sealants And Tissue Patches Market?

The surgical sealants and tissue patches market consists of revenues earned by entities by providing services such as wound closure, leak prevention, hemostasis management, tissue adhesion, reinforcement of surgical repairs and postoperative healing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The surgical sealants and tissue patches market also includes sales of hemostatic agents, collagen-based patches, protein-based adhesives and bioresorbable patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.